GAPDH and breast cancer: The genosensor was applied to human samples by immunocapturingthe exosomes directly from serum from breast cancer patients and showeda higher electrochemical signal (3.3-fold, p <0.05), when compared with healthy controls, suggesting an overexpressionof GAPDH on serum-derived exosomes from breast cancer patients.